FDA inspection
Taizhou Hisound Pharmaceutical Co. Ltd.: FDA inspection ending May 6, 2026
FDA inspection 1322968 · No Action Indicated (NAI) · Linhai
Key facts
| Inspection ID | 1322968 |
|---|---|
| Firm | Taizhou Hisound Pharmaceutical Co. Ltd. |
| FEI number | 3006355441 |
| Address | No. 22 Nanyang First Road, Zhejiang Provincial Chemical And Medical Materials Base Linhai Zone |
| City | Linhai |
| Country | China |
| Fiscal year | 2026 |
| Inspection end date | May 6, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Foodborne Biological Hazards |
| Product type | Food/Cosmetics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data